The Cooperative Centers on Human Immunology (CCHI) program is offering this grant to interdisciplinary teams to conduct mechanistic and hypothesis-testing studies. This funding aims to discover novel molecules, mechanisms, or regulatory pathways governing human immune system function. Research should encompass both healthy and vulnerable populations, including across the lifespan, organ transplant recipients, and pregnant women. Studies of interest cover immunity related to infectious disease prevention/treatment, immune-mediated pathogenesis, and immune-mediated diseases. The grant also supports technology development for advancing human immune system studies. This grant is for providing foundational information on human immune function to translate immunology research into clinical benefits.
Opportunity ID: 344505
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-22-069 |
Funding Opportunity Title: | Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 15, 2022 |
Last Updated Date: | Nov 15, 2022 |
Original Closing Date for Applications: | Apr 07, 2023 |
Current Closing Date for Applications: | Apr 07, 2023 |
Archive Date: | May 13, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | $2,500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) seeks to solicit applications from interdisciplinary teams to participate in the Cooperative Centers on Human Immunology (CCHI) program. The program supports mechanistic and hypothesis-testing studies to discover novel molecules, mechanisms, or regulatory pathways governing function of the human immune system in both healthy and vulnerable populations (i.e., across lifespan, organ/tissue transplant recipients, pregnant women). Studies of interest include immunity related to prevention or treatment of infectious diseases, immune-mediated pathogenesis/sequelae associated with infectious disease, and/or immune-mediated diseases. This FOA also supports technology development to advance studies of the human immune system. The overarching goal of the CCHI is to provide foundational information on human immune system function to support translation of immunology research into clinical benefits. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-069.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 344505 Full Announcement-RFA-AI-22-069 -> RFA-AI-22-069-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278729 | Mar 07, 2023 | Apr 07, 2023 | View |
Package 1
Mandatory forms
344505 RR_SF424_5_0-5.0.pdf
344505 PHS398_CoverPageSupplement_5_0-5.0.pdf
344505 RR_OtherProjectInfo_1_4-1.4.pdf
344505 PerformanceSite_4_0-4.0.pdf
344505 RR_KeyPersonExpanded_4_0-4.0.pdf
344505 PHS398_ResearchPlan_5_0-5.0.pdf
344505 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344505 PHS_Additional_IndirectCosts_2_0-2.0.pdf
344505 PHS_AssignmentRequestForm_3_0-3.0.pdf